Riset & Studi Klinis di Balik Produk G-NiiB
G-NiiB percaya pada kekuatan solusi kesehatan berbasis ilmiah. Setiap produk kami didukung oleh studi klinis yang komprehensif, memastikan yang terbaik untuk kesehatan Anda.
Riset & Studi Klinis
Joint CUHK-HKU Study Discovers Efficacy of Novel Virus Vaccines Correlates with a Probiotic Bacterium, Bifidobacterium Adolescentis
Prevention and Treatment of Post Novel Virus Conditions with CUHK Immunity Formula (SIM01)
Microbiome Imbalance Might Influence “Post Novel Virus Conditions” Risk
CU Medicine Study Shows Modulation of Gut Microbiota Helps Enhance Safety and Efficacy of Novel Virus Vaccine
Among 1,000 Healthy People in Hong Kong, Nearly 40% of Them Have the Phenomenon of Intestinal Flora Imbalance
CUHK Microbiome Immunity Formula Hastens Recovery of Novel Virus Patients and Offers Hope to Boost Immunity
Novel Virus and the Microbiome
Probiotik yang Didukung oleh Riset Klinis
Rasakan manfaat dari rangkaian suplemen probiotik yang diformulasikan secara presisi dan berdasarkan rangkaian studi klinis.
BELI SEKARANG